News | October 16, 2024
Strides Pharma's CDMO arm OneSource raises Rs. 801 crore in pre-listing round
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
Aims to achieve CDMO sales of US$ 400 million by 2028
The acquisition will strengthen the overall company’s position as leading global CRO services partner
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
More than 10 oral and mini-oral presentations span Pfizer’s extensive Oncology portfolio of approved and investigational therapies
Subscribe To Our Newsletter & Stay Updated
